Comparative analysis of retrospective and current evaluation of life quality for patients with inhibitor form of hemophilia treated with Novoseven medication

Comparative analysis of retrospective and current evaluation of life quality for patients with inhibitor form of hemophilia treated with Novoseven medication

.

Saved in:

Bibliographic Details
Main Authors:	N. I. Zozulya, G. A. Arina
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2008-12-01
Series:	Бюллетень сибирской медицины
Online Access:	https://bulletin.ssmu.ru/jour/article/view/3907
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experience of induction of immune tolerance in patients with inhibitor form of hemophilia A in the presence of negative prognostic factors
by: N. I. Zozulya
Published: (2008-12-01)

Screening of hemophilia patients for detection of inhibitors to fibrillation factors and development of personified treatment
by: N. I. Zozulya, et al.
Published: (2008-12-01)

MANAGEMENT OF INHIBITORS IN HEMOPHILIA
by: Gaye Kalacı Katayıfçı
Published: (2024-12-01)

Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation
by: Novak Vesna, et al.
Published: (2007-01-01)

Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
by: Himani Chand, et al.
Published: (2025-03-01)

Advantages of palatal cystotomy, demanded for treating cystic structures in the patient with inhibitors hemophilia A
Published: (2020-04-01)

Acquired hemophilia in patient with Systemic lupus erythematosus: Clinical case report
by: S. A. Alekseeva, et al.
Published: (2025-07-01)

Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
by: Nina A. Petunina, et al.
Published: (2016-12-01)

Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01)

Exploration of biomarkers for inhibitor development in persons with hemophilia A
by: Meng-Ni Fan, et al.
Published: (2025-05-01)

TSUBASA study: evaluation of the quality and content of daily life of people with hemophilia A without factor VIII inhibitors on prophylactic treatment with emicizumab
by: Teruhisa Fujii, et al.
Published: (2025-07-01)

Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
by: Nicholas B. Abt, et al.
Published: (2014-01-01)

Predictors of Health-Related Quality of Life in Adult Hemophilia Patients in Cipto Mangunkusumo Hospital
by: Findy Prasetyawaty, et al.
Published: (2016-09-01)

The Health-Related Quality of Life scores and joint health in children and young adults with hemophilia
by: Buse Günyel, et al.
Published: (2024-12-01)

Development of a short form of the Swedish version of the Hemophilia Activities List
by: Elisabeth Brodin, et al.
Published: (2025-07-01)

Serum Vitamin D in Children with Hemophilia A and Its Association with Joint Health and Quality of Life
by: Aida M. S. Salem, et al.
Published: (2024-11-01)

Research progress on clinical application of anti-tissue factor pathway inhibitor in hemophilia
by: XIAO Jianwen, YI Weijia
Published: (2025-04-01)

CO30 | Joint prosthetic surgery in patients with hemophilia A: clinical-functional outcomes and quality of life
Published: (2025-08-01)

The effect of prophylactic FVIII infusion combined with personalized rehabilitation on joint health and quality of life in children with hemophilia
by: Yaojin Sun, et al.
Published: (2025-07-01)

Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question
by: Catalina GURAN, et al.
Published: (2025-03-01)

HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group
by: Márcio Antônio Portugal Santana, et al.
Published: (2024-12-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

HEMOPHILIA: ADVANCES IN TREATMENTS
by: Nurgül Karakaya
Published: (2024-12-01)

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options
by: Bülent Zülfikar, et al.
Published: (2024-10-01)

Impact of intermediate-dose tertiary prophylaxis on quality of life and psychological aspects of adult patients with severe/moderate hemophilia A
by: Hua Gao, et al.
Published: (2025-12-01)

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
by: Kathelijn Fischer, et al.
Published: (2025-05-01)

Successful bleeding control of refractory hemothorax in two hemophilia A patients with high-titer inhibitors
by: Ting-Chih Lin, et al.
Published: (2020-06-01)

New Treatment Modalities in Hemophilia
by: Kaan Kavaklı
Published: (2022-03-01)

Clinical case of an acquired hemophilia
by: P. N. Barlamov, et al.
Published: (2020-01-01)

Gene-based therapies for hemophilia
by: Melissa F. Glasner, et al.
Published: (2025-05-01)

Hemophilia treatments and the paradox of choice
by: Mike Makris, et al.
Published: (2025-02-01)

PO90 | Acquired hemophilia A with high-titer inhibitor in a patient with cardiovascular and metabolic comorbidities
Published: (2025-08-01)

Cost-minimization and budget impact analysis of bypassing agents in hemophilia A with inhibitors: a Brazilian study
by: Christiane Maria da Silva Pinto, et al.
Published: (2025-08-01)

Inhibitor development and clinical characteristics in children with severe hemophilia A in the ATHN 8 US cohort study
by: Courtney D. Thornburg, et al.
Published: (2025-08-01)

Intracranial Hemorrhage in a Patient of Hemophilia A with Factor VIII Inhibitors Positive: A Case Report
by: Melvin K. Ninan, et al.

Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia A
by: Meganathan Kannan PhD, et al.
Published: (2025-03-01)

Retrospective analysis of clinical data from 171 low-income patients with hemophilia in Shandong Province
by: Jie Wang, et al.
Published: (2025-02-01)

CO36 | Inhibitor titer at diagnosis and clinical course in acquired hemophilia A: a single-center experience
Published: (2025-08-01)

Genomic ancestry, F8 variants, and immune tolerance in hemophilia A patients with inhibitors: exome sequencing insights
by: Hanaisa Sant’Anna, et al.
Published: (2025-05-01)